Boston Partners
SRTA

Boston Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Boston Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Buy
84,833
+18,057
+27% +$86.9K ﹤0.01% 713
2025
Q4 		$321K Sell
66,776
-8,695
-12% -$42.1K ﹤0.01% 721
2025
Q3 		$382K Sell
75,471
-109,238
-59% -$483K ﹤0.01% 701
2025
Q2 		$744K Sell
184,709
-202,900
-52% -$660K ﹤0.01% 620
2025
Q1 		$1.06M Buy
387,609
+181,819
+88% +$652K ﹤0.01% 559
2024
Q4 		$875K Sell
205,790
-3,165
-2% -$12K ﹤0.01% 581
2024
Q3 		$614K Buy
+208,955
New +$665K ﹤0.01% 659

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners's SRTA Position: Q1 2026 in Review

Boston Partners increased its Strata Critical Medical Inc (SRTA) stake by 27% in Q1 2026, buying an estimated $86.9K and bringing the position to 84,833 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Boston Partners first reported a position in SRTA in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.06M in Q1 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Boston Partners held 84,833 shares of Strata Critical Medical Inc worth $355K as of Q1 2026.
  • Boston Partners bought 18,057 Strata Critical Medical Inc shares in Q1 2026, an estimated $86.9K.
  • Strata Critical Medical Inc made up ﹤0.01% of Boston Partners's portfolio in Q1 2026, its #713 holding.
  • Boston Partners first reported a position in Strata Critical Medical Inc in Q3 2024 and has held it in 7 quarters since.
  • Boston Partners's Strata Critical Medical Inc position peaked at $1.06M in Q1 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.